Financial Counselors Inc Innoviva, Inc. Transaction History

Financial Counselors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $4,366 - $5,098	370 Added 3.4%	11,250 $149,000
Q3 2022 Nov 01, 2022	BUY	$11.61 - $15.22 $126,316 - $165,593	10,880 New	10,880 $126,000
Q1 2022 Apr 28, 2022	SELL	$15.39 - $20.25 $158,209 - $208,170	-10,280 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$15.91 - $18.72 $163,554 - $192,441	10,280 New	10,280 $177,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Counselors Inc with notifications on news.